Venus Remedies Secures Reo Certification From Cii For Second Consecutive Year

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Venus Remedies secures REO Certification from CII for second consecutive year

ri-calendar-2-lineOct 20, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

Venus Remedies proudly announces its consecutive achievement of the esteemed Responsible Export Organisation (REO) certification from the Confederation of Indian Industry (CII). This recognition for the second year running underscores the company's steadfast dedication to excellence in the pharmaceutical sector.

 

As the inaugural pharmaceutical company in India to receive the REO certification from CII, Venus Remedies leads in responsible and sustainable export practices. This acknowledgment follows a rigorous evaluation, emphasizing the company's commitment to upholding the highest standards of quality and integrity.

 

The REO certification is an esteemed accolade presented by the Confederation of Indian Industry to firms exemplifying extraordinary dedication to responsible and sustainable export practices, ensuring elevated levels of quality, ethics, and integrity in their global business endeavors.

 

This certification amplifies Venus Remedies' commitment to responsible and ethical business conduct, establishing the company as a trailblazer in the global pharmaceutical landscape. It mirrors the comprehensive evaluation and validation of the organization's systems and procedures as exemplary within the industry.

 

Mr. Peeyush Jain stated, "This certification will empower our company to continue its upward trajectory and solidify its position as an export industry leader." He further expressed pride in the accomplishment, crediting the dedicated team's hard work. Venus Remedies remains resolute in its mission to make a positive impact in the pharmaceutical industry, consistently striving for excellence, innovation, and the delivery of high-quality healthcare solutions on a global scale.

Related News

News Thumbnail
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

News Thumbnail
Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

News Thumbnail
Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

News Thumbnail
Company

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr

4 mins read. August 2, 2024 at 12:33 PM

Related Blogs

Stock chartCommodities

Why Gold Remains a Safe Haven Amid Global Economic Shifts in 2025

0 people read

4 mins read . Sep 5, 2025

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions